Fold change based approach for identification of significant network markers in breast,lung and prostate cancer

Cancer belongs to a class of highly aggressive diseases and a leading cause of death in the world. With more than 100 types of cancers, breast, lung and prostate cancer remain to be the most common types. To identify essential network markers (NMs) and therapeutic targets in these cancers, the authors present a novel approach which uses gene expression data from microarray and RNA‐seq platforms and utilises the results from this data to evaluate protein–protein interaction (PPI) network. Differentially expressed genes (DEGs) are extracted from microarray data using three different statistical methods in R, to produce a consistent set of genes. Also, DEGs are extracted from RNA‐seq data for the same three cancer types. DEG sets found to be common in both platforms are obtained at three fold change (FC) cut‐off levels to accurately identify the level of change in expression of these genes in all three cancers. A cancer network is built using PPI data characterising gene sets at log‐FC (LFC)>1, LFC>1.5 and LFC>2, and interconnection between principal hub nodes of these networks is observed. Resulting network of hubs at three FC levels highlights prime NMs with high confidence in multiple cancers as validated by Gene Ontology functional enrichment and maximal complete subgraphs from CFinder.Inspec keywords: cancer, proteins, RNA, bioinformatics, statistical analysis, genetics, molecular biophysics, ontologies (artificial intelligence), lungOther keywords: cancer network, PPI data, gene sets, multiple cancers, Gene Ontology functional enrichment, prostate cancer, gene expression data, RNA‐seq platforms, protein–protein interaction network, DEG, microarray data, RNA‐seq data, cancer types, lung cancer, diseases, breast cancer, network markers, differentially expressed genes, fold change based approach, CFinder, statistical methods